Maternal serum soluble HLA-G in complicated pregnancies

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 27, Issue 4, 2014, Pages 381-384

  Biyik, Ismail ^a  

^a Karacabey State Hospital   (Turkey)

Author keywords

First trimester; Preeclampsia; Soluble HLA G

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; HLA G ANTIGEN; HLA G1 ANTIGEN; HLA G5 ANTIGEN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; APGAR SCORE; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HIGH RISK PREGNANCY; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL BLOOD; NUCHAL TRANSLUCENCY MEASUREMENT; OLIGOHYDRAMNIOS; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; BLOOD; FOLLOW UP; MATERNAL SERUM SCREENING TEST; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HLA-G ANTIGENS; HUMANS; MATERNAL SERUM SCREENING TESTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84892710899     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.818126     Document Type: Article

References (29)

1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-22.
2. Hill LM. Oligohydramnios: sonographic diagnosis and clinical implications. Clin Obstet Gynecol 1997;40:314-27.
3. ACOG practice bulletin. Management of preterm labor. Number 43, May 2003. Int J Gynaecol Obstet 2003;82:127-35.
4. ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol 2007;109:1007-19.
5. Maulik D. Fetal growth restriction: the etiology. Clin Obstet Gynecol 2006;49:228-35.
6. Maulik D, Frances Evans J, Ragolia L. Fetal growth restriction: pathogenic mechanisms. Clin Obstet Gynecol 2006;49:219-27.
7. Kim YM, Chaiworapongsa T, Gomez R, et al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002;187:1137-42.
8. Kim YM, Bujold E, Chaiworapongsa T, et al. Failure of physiologic transformation of the spiral arteries inpatients with preterm labor and intact membranes. Am J Obstet Gynecol 2003;189:1063-9.
9. Le Bouteiller P, Mallet V. HLA-G and pregnancy. Rev Reprod 1997;2:7-13.
10. Ober C. HLA and pregnancy: the paradox of the fetal allograft. Am J Hum Genet 1998;62:1-5.
11. Puppo F, Costa M, Contini P, et al. Determination of soluble HLA-G and HLA-A,-B, and-C molecules in pregnancy. Transplant Proc 1999;31:1841-3.
12. Hunt JS, Jadhav L, Chu W, et al. Soluble HLA-G circulates in maternal blood during pregnancy. Am J Obstet Gynecol 2000;183: 682-8.
13. Roussev RG, Coulam CB. HLA-G and its role in implantation (review). J Assist Reprod Genet 2007;24:288-95.
14. Sargent IL. Does 'soluble' HLA-G really exist? Another twist to the tale. Mol Hum Reprod 2005;11:695-8.
15. Hunt JS, Petroff MG, McIntire RH, Ober C. HLA-G and immune tolerance in pregnancy. FASEB J 2005;19:681-93.
16. Roussev RG, Ng SC, Coulam CB. Natural killer cell functional activity suppression by intravenous immunoglobulin, intralipid and soluble human leukocyte antigen-G. Am J Reprod Immunol 2007; 57:262-9.
17. Morales PJ, Pace JL, Platt JS, et al. Synthesis of beta(2)-microglobulin- free, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells. Immunology 2007; 122:179-88.
18. Le Bouteiller P. HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83(\+) dendritic cells expresses HLA-G as a membrane-boundand soluble protein. Int Immunol 1999;11:889-98.
19. O'Brien M, Dausset J, Carosella ED, Moreau P. Analysis of the role of HLA-G inpreeclampsia. Hum Immunol 2000;61:126-31.
20. Goldman-Wohl DS, Ariel I, Greenfield C, et al. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with preeclampsia. Mol Hum Reprod 2000;6: 88-95.
21. Van Lierop MJ, Wijnands F, Loke YW, et al. Detection of HLA-G by a specific sandwich ELISA using monoclonal antibodies G233 and 56B. Mol Hum Reprod 2002;8:776-84.
22. Redman CW. Immunology of preeclampsia. Semin Perinatol 1991; 15:257-62.
23. Hara N, Fujii T, Yamashita T, et al. Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblasts in preeclampsia: immunohistological demonstration with anti-HLA-G specific antibody "87G" and anti-cytokeratin antibody "CAM5.2". Am J Reprod Immunol 1996;36:349-58.
24. Yie SM, Li LH, Li YM, Librach C. HLA-G protein concentrations in maternal serum and placental tissue are decreasedin preeclampsia. Am J Obstet Gynecol 2004;191:525-9.
25. Steinborn A, Varkonyi T, Scharf A, et al. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. Am J Reprod Immunol 2007; 57:277-86.
26. Darmochwal-Kolarz D, Kolarz B, Rolinski J, et al. The concentrations of soluble HLA-G protein are elevated during mid-gestation and decreased in preeclampsia. Folia Histochem Cytobiol 2012;50: 286-91.
27. Rizzo R, Andersen AS, Lassen MR, et al. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy. Am J Reprod Immunol 2009;62:320-38.
28. Yie SM, Taylor RN, Librach C. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy. Am J Obstet Gynecol 2005;193: 204-8.
29. Hackmon R, Koifman A, Hyodo H, et al. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. Am J Obstet Gynecol 2007;197:255.e1-5.